Field guide

Copper Peptides, Explained: The Best-Evidenced Peptide With the Thinnest Trials

GHK-Cu is a naturally occurring tripeptide, glycine, histidine, and lysine, bound to a copper ion, first identified in human blood plasma by Loren Pickart in 1973. In cell work it stimulates fibroblasts to make collagen types I and III, elastin, and glycosaminoglycans. The human evidence is one double-blind serum trial of 40 women over 8 weeks, where wrinkle volume fell 24.1 percent against 15.0 percent for the plain serum base. Promising, not proven.

Copper peptides get sold as the ingredient with the deepest science in skincare, and half of that claim is true. The mechanistic literature is enormous: GHK-Cu modulates the expression of thousands of genes involved in tissue repair, it upregulates collagen I and III, elastin, decorin, and glycosaminoglycans in fibroblasts, and it rebalances the enzymes that build matrix against the ones that break it down. The other half of the claim is where the trouble starts. Most of that evidence is cells in dishes and rats with wounds, not faces in trials.

GHK-Cu is a fragment of collagen alpha-2(I) that binds copper(II) with almost ideal affinity, so it acts as a shuttle rather than a chelator. Your body makes it, and plasma levels fall with age, from about 200 ng per mL at age 20 to about 80 ng per mL at age 60. That decline is the rationale for replacing it topically. The rationale is elegant. The trials are not.

What the human trials actually found

The only GHK-Cu trial with a serum vehicle is the Auckland study: 40 women used a GHK-Cu serum for 8 weeks, double-blind, and wrinkle volume fell 24.1 percent on the treated side against 15.0 percent with the plain serum base. Read that again, because the base matters. The plain serum with no copper also smoothed wrinkles, which is what a good moisturizer does, and the copper added about nine points on top. In the same trial, 39 of 40 women tolerated the products for the full 8 weeks.

An older study by Leyden and colleagues from 2002 measured a 17 percent improvement in skin elasticity by cutometer against placebo. A 2026 systematic review and meta-analysis of randomized controlled trials found peptide interventions improved some measures of hydration and brightness, while wrinkle and elasticity outcomes varied. That is the whole human record for the best-evidenced cosmetic peptide there is: small, short, mostly industry-funded, and honest about its own limits.

The concentration question nobody has answered

Effective cosmetic concentrations run 0.1 to 1 percent by weight. Below 0.05 percent you are mostly buying the blue color. Above 2 percent, irritation climbs without added benefit. One percent is the most common stated strength, and it works out to about 10 mg of GHK-Cu per mL in a water-based serum, or about 300 mg in a 30 mL bottle. That is a reasonable default. It is not a proven optimum, because no published trial has compared 1 percent with 4 percent, and the 2016 serum trial did not publish its GHK-Cu strength at all.

There is also a wrinkle in the mechanism that the marketing never mentions. A 2015 review notes GHK-Cu stimulates both the synthesis and the breakdown of collagen, which makes the idea that heavy use tips the balance toward breakdown plausible, though unproven. In cell work from the same team behind the serum trial, collagen output went down as the GHK-Cu dose went up. If 1 percent is not working, 3 percent will not work either. It will just make your face sting and stain your pillowcase.

How to buy one without getting played

Look for the INCI name Copper Tripeptide-1 on the ingredient list, and a stated strength of 0.1 to 1 percent. Allow at least 8 weeks of daily use before judging it, since the only trial that showed anything ran 8 weeks. Sensitive and rosacea-prone skin often tops out around 0.2 percent, so start low and step up over two to three weeks if there is no stinging or flaking.

Do not buy it as a collagen rebuild. The laboratory evidence is promising, but strong clinical evidence for rapid collagen rebuilding from topical GHK-Cu is lacking, and claims about reprogramming skin cells go beyond what the current evidence can establish. Buy it as an optional, well-tolerated supportive ingredient with a real mechanism and a thin trial record, and keep the retinoid for the job that actually has decades of human data behind it.

Frequently asked questions

What are copper peptides in skincare?

GHK-Cu is a tripeptide of glycine, histidine, and lysine bound to a copper ion, naturally present in human blood plasma. It stimulates fibroblasts to produce collagen, elastin, and glycosaminoglycans in cell studies, and it is listed on ingredient labels as Copper Tripeptide-1.

What concentration of copper peptides works?

Cosmetic concentrations run 0.1 to 1 percent, with 1 percent the most common stated strength. No trial has compared 1 percent with 4 percent, so 1 percent is a sensible default rather than a proven optimum. Above 2 percent, irritation climbs without added benefit.

Do copper peptides rebuild collagen?

In laboratory studies, yes, GHK-Cu increases collagen production in fibroblasts. In human skin, the evidence is limited to small, short trials, and strong clinical proof of rapid collagen rebuilding from a topical serum is lacking. Treat it as supportive, not as a proven regeneration treatment.

How long does it take for copper peptides to work?

Allow at least 8 weeks of daily use. The only double-blind serum trial ran 8 weeks, and wrinkle volume fell 24.1 percent against 15.0 percent for the plain serum base, so the copper added a modest improvement on top of what the moisturizer base did alone.